Research programme: pain therapeutics - Domain Therapeutics/ ConectusAlternative Names: Neuropeptide FF - Domain Therapeutics/Conectus; THIAPO 2
Latest Information Update: 20 Sep 2016
At a glance
- Originator Domain Therapeutics
- Class Analgesics
- Mechanism of Action Neuropeptide modulators
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity Yes
Highest Development Phases
- Research Pain
Most Recent Events
- 19 Sep 2016 Early research in Pain in France (unspecified route) before September 2016